tradingkey.logo
搜尋

AVITA Medical Inc

RCEL
添加自選
5.060USD
+0.390+8.35%
收盤 07/02, 13:00美東報價延遲15分鐘
155.73M總市值
虧損本益比TTM

關於 AVITA Medical Inc 公司

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

AVITA Medical Inc簡介

公司代碼RCEL
公司名稱AVITA Medical Inc
上市日期Mar 18, 2012
CEOVance (Cary G)
員工數量260
證券類型Ordinary Share
年結日Mar 18
公司地址28159 Avenue Stanford
城市VALENCIA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編91355
電話16613679170
網址https://www.avitamedical.com/
公司代碼RCEL
上市日期Mar 18, 2012
CEOVance (Cary G)

AVITA Medical Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--

常見問題

AVITA Medical Inc的前五大股東是誰?

AVITA Medical Inc的前五大股東如下:Prof. Suzanne Crowe

有多少機構持有AVITA Medical Inc(RCEL)的股份?

截至2026Q1,共有209家機構持有AVITA Medical Inc的股份,合計持有的股份價值約為6.52M,占公司總股份的21.20% 。與2025Q4相比,機構持股有所增加,增幅為-1392153.00。